Literature DB >> 28560711

Recent advances in hypertrophic scar.

Julei Zhang1, Yan Li1, Xiaozhi Bai1, Yuehua Li1, Jihong Shi2, Dahai Hu3.   

Abstract

Hypertrophic scars (HTS) are predominant diseases after burn and trauma, which cause severe physiological and psychological problems. HTS have been researched for decades, and our knowledge about the mechanisms of HTS formation process has been increasing. However, the effects of currently available prevention and treatment strategies are limited. In this review, we summarize currently known mechanisms and recent studies of HTS, including extracellular matrix, matrix metalloproteinases, fibroblasts, myofibroblasts and their contraction ability, keratinocytes, growth factors, inflammatory and immune response, and stem cell treatment, hoping for a better understanding of HTS generation, development and effective translation to treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28560711     DOI: 10.14670/HH-11-908

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  18 in total

Review 1.  The Ubiquitin Proteasome System and Skin Fibrosis.

Authors:  Wanlu Shen; Zhigang Zhang; Jiaqing Ma; Di Lu; Lechun Lyu
Journal:  Mol Diagn Ther       Date:  2021-01-12       Impact factor: 4.074

2.  Development of a Porcine Full-Thickness Burn Hypertrophic Scar Model and Investigation of the Effects of Shikonin on Hypertrophic Scar Remediation.

Authors:  Xingwang Deng; Qian Chen; Lijuan Qiang; Mingwei Chi; Nan Xie; Yinsheng Wu; Ming Yao; Dan Zhao; Jiaxiang Ma; Ning Zhang; Yan Xie
Journal:  Front Pharmacol       Date:  2018-06-05       Impact factor: 5.810

3.  Cuprous oxide nanoparticles reduces hypertrophic scarring by inducing fibroblast apoptosis.

Authors:  Yongqiang Xiao; Dayuan Xu; Hongyuan Song; Shichu Xiao; Futing Shu; Pei Wei; Xiaolan Yang; Chenjian Zhong; Xiaohong Wang; Werner Eg Müller; YongJun Zheng; Zhaofan Xia
Journal:  Int J Nanomedicine       Date:  2019-07-30

4.  Effect of pressure therapy for treatment of hypertrophic scar.

Authors:  Hao Zhang; Hao-Yan Wang; Da-Li Wang; Xiao-Dong Zhang
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

5.  Bone marrow concentrate-induced mesenchymal stem cell conditioned medium facilitates wound healing and prevents hypertrophic scar formation in a rabbit ear model.

Authors:  Ching-Hsuan Hu; Yi-Wen Tseng; Chih-Yung Chiou; Kuan-Chun Lan; Chih-Hung Chou; Chun-San Tai; Hsien-Da Huang; Chiung-Wen Hu; Ko-Hsun Liao; Shiow-Shuh Chuang; Jui-Yung Yang; Oscar K Lee
Journal:  Stem Cell Res Ther       Date:  2019-08-28       Impact factor: 6.832

6.  Effect of artesunate and relation with TGF-β1 and SMAD3 signaling on experimental hypertrophic scar model in rabbit ear.

Authors:  Xiaolin Nong; Girju Rajbanshi; Ling Chen; Jiaquan Li; Zhan Li; Taotao Liu; Shihai Chen; Gao Wei; Jushang Li
Journal:  Arch Dermatol Res       Date:  2019-08-09       Impact factor: 3.017

7.  595-nm pulsed dye laser combined with fractional CO2 laser reduces hypertrophic scar through down-regulating TGFβ1 and PCNA.

Authors:  Jinxia Zhang; Shuanglin Zhou; Zhikuan Xia; Zhuoying Peng; Xiaoxian Cheng; Xin Yang; Wanting Luo; Rongya Yang
Journal:  Lasers Med Sci       Date:  2021-06-12       Impact factor: 3.161

8.  [Curcumol inhibits keloid fibroblast proliferation and collagen synthesis through the ERK signaling pathway].

Authors:  W Yuan; H Sun; L Yu; J Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-05-20

9.  Aberrantly expressed long noncoding RNAs in hypertrophic scar fibroblasts in vitro: A microarray study.

Authors:  Longxiang Tu; Qi Huang; Shangfeng Fu; Dewu Liu
Journal:  Int J Mol Med       Date:  2018-01-26       Impact factor: 4.101

10.  Arctigenin suppresses fibroblast activity and extracellular matrix deposition in hypertrophic scarring by reducing inflammation and oxidative stress.

Authors:  Ling Jiang; Ying Deng; Wei Li; Yang Lu
Journal:  Mol Med Rep       Date:  2020-09-25       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.